96 related articles for article (PubMed ID: 6754331)
1. [Palatinite in type II diabetics. Effect on blood-glucose, serum-insulin, C-peptide and free fatty acids].
Petzoldt R; Lauer P; Spengler M; Schöffling K
Dtsch Med Wochenschr; 1982 Dec; 107(50):1910-3. PubMed ID: 6754331
[TBL] [Abstract][Full Text] [Related]
2. [Sugar substitutes in the diabetic diet].
Mehnert H
Int Z Vitam Ernahrungsforsch Beih; 1976; 15():295-324. PubMed ID: 783058
[TBL] [Abstract][Full Text] [Related]
3. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
[TBL] [Abstract][Full Text] [Related]
4. [Levels of serum insulin and free fatty acids as well as glycemia following food intake in obese diabetics].
Páv J
Vnitr Lek; 1978 Sep; 24(9):875-83. PubMed ID: 695355
[No Abstract] [Full Text] [Related]
5. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral administration of erythritol on patients with diabetes.
Ishikawa M; Miyashita M; Kawashima Y; Nakamura T; Saitou N; Modderman J
Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 2):S303-8. PubMed ID: 8933647
[TBL] [Abstract][Full Text] [Related]
7. Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy.
Taskinen MR; Bogardus C; Kennedy A; Howard BV
J Clin Invest; 1985 Aug; 76(2):637-44. PubMed ID: 3897287
[TBL] [Abstract][Full Text] [Related]
8. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
[No Abstract] [Full Text] [Related]
9. [Effect of Inderal on insulin secretion, blood sugar and free fatty acids in healthy controls and diabetics].
Eisner M; Dobrohorska H; Stachowski A; Malinowska M; Tustanowski S
Pol Tyg Lek; 1975 Apr; 30(14):585-8. PubMed ID: 1129201
[No Abstract] [Full Text] [Related]
10. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
Adibi SA; Morse EL; Amin PM
J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
[TBL] [Abstract][Full Text] [Related]
11. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and hormonal profile of the offsprings of conjugal diabetics.
Mahtab H; Ara S; Banik NG; Chowdhury NA; Azad Khan AK
Bangladesh Med Res Counc Bull; 1982 Jun; 8(1):7-14. PubMed ID: 6756373
[TBL] [Abstract][Full Text] [Related]
13. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
Rosak C; Hofmann U; Paulwitz O
Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
[TBL] [Abstract][Full Text] [Related]
14. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
Klein O; Lynge J; Endahl L; Damholt B; Nosek L; Heise T
Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154
[TBL] [Abstract][Full Text] [Related]
15. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Giugliano D; Luyckx AS; Lefebvre PJ
Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
[TBL] [Abstract][Full Text] [Related]
16. [Glisoxepide treatment in maturity-onset diabetics (author's transl)].
Happ J; Beyer J; Ulreich F; Schöffling K; Krause U; Frönlich A
Dtsch Med Wochenschr; 1976 Nov; 101(45):1643-6. PubMed ID: 1033056
[TBL] [Abstract][Full Text] [Related]
17. Response of plasma insulin, serum free fatty acids and blood glucose in growth onset diabetics, to I.V. tolbutamide.
Kirti S; Dutta PK; Vaishnava H; Singh RB
J Assoc Physicians India; 1976 Mar; 24(3):141-6. PubMed ID: 1010812
[No Abstract] [Full Text] [Related]
18. [The impact of calpain-10 gene combined-SNP variation on type 2 diabetes mellitus and its related metabolic traits].
Xiang K; Fang Q; Zheng T; Jia W; Wang Y; Zhang R; Li J; Shen K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):426-30. PubMed ID: 11774208
[TBL] [Abstract][Full Text] [Related]
19. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
[TBL] [Abstract][Full Text] [Related]
20. Blood sugar serum insulin and free fatty acid levels in normal dogs. Sex differences.
Renauld A; Sverdlik RC
Acta Physiol Lat Am; 1975; 25(6):458-61. PubMed ID: 1235459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
